SAT-515 Cholangiocarcinoma across England: evidence of regional, socioeconomic, and temporal variations in incidence, survival, routes to diagnosis and treatment
Sophie José, Shahid Ali Khan(King Abdulaziz University), Lizz Paley, Mireille B. Toledano(St Mary's Hospital), Amy Zalin, Daniela Tataru(National Health Service), Roger Cherry, Helen Morement(CRUK Lung Cancer Centre of Excellence), Kwok Wong(NHS Digital), Craig Knott(Insight Healthcare)
Cited by 0
Related Papers
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
|The Lancet Oncology|2019|1.2k
Changing international trends in mortality rates for liver, biliary and pancreatic tumours
|Journal of Hepatology|2002|592
Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968–1998
|Gut|2001|380
Rising trends in cholangiocarcinoma: Is the ICD classification system misleading us?
|Journal of Hepatology|2011|285
Comprehensive review on naringenin and naringin polyphenols as a potent anticancer agent
|Environmental Science and Pollution Research|2022|103